Liquid error: undefined method `to_liquid' for # Stories | Patient Daily

Regulatory

Press release submission | Jan 15, 2022

Glenmark Specialty S.A. (Switzerland) receives NDA Approval by the USFDA for Ryaltris™ Nasal Spray for the Treatment of Symptoms of Seasonal Allergic Rhinitis

Press release submission | Jan 14, 2022

KILI Medical Drain Carrier Reduces Post-Op Hospital Visits for Cancer Patients, Receives Patent

Press release submission | Jan 12, 2022

Efficacy Expectations for Refractory Migraine Patients are Vital for Strong Uptake of Impel's Trudhesa, Spherix Reports

Press release submission | Jan 7, 2022

100% Recovery-GoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients

Press release submission | Jan 6, 2022

Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer

Press release submission | Jan 5, 2022

NRx Pharmaceuticals Submits Emergency Use Authorization Application to US Food and Drug Administration for ZYESAMI® (aviptadil) to Treat Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approved Therapies

Bree Gonzales | Jan 5, 2022

Biden: 'We’re mobilizing an additional 1,000 military doctors and nurses to help staff hospitals'

Bree Gonzales | Jan 4, 2022

The No Surprises Act took effect Jan. 1: 'Its effect will eventually be felt by literally everybody'

Trending

+ Pharmaceuticals

Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals

Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals

Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes